Scarica l'app Stockscreener
0.0005
9,900%
0.00
Vaxxinity Inc Borsa (VAXX) Ultime notizie
Vaxxinity Shares Plummet Amid Extreme Volatility - AD HOC NEWS
Analyzing Vaxxinity (NASDAQ:VAXX) & Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Tangible book value per share of Vaxxinity, Inc. – OTC:VAXX - TradingView
Hypercholesterolemia Pipeline Drugs Report 2025: MOA, Emerging Therapies, Clinical Trials, Treatment | DelveInsight - Barchart.com
Space Medicine Market Report 2025 | Innovative Space-Based Regenerative Medicine Aims to Enhance Human Health During Long-Duration Missions - 24matins.uk
Hypercholesterolemia Pipeline 2025: Innovative Clinical Advancements by 25+ Global Leaders – DelveInsight | Featuring companies such as Jiangsu HengRui Medicine Co., Ltd., Merck Sharp & Dohme LLC, Arr - Barchart.com
Dallas District Court Split in High-Stakes Stock Dispute - Inforney News
Migraine Pipeline 2025: MOA, ROA, and Clinical Trial Insights Explored | GlaxoSmithKline, Merck & Co., Inc., Pfizer, Bausch Health, Amgen, Abbvie Inc., AstraZeneca, Eli Lilly and Co - Barchart.com
Local Man Arrested on Multiple Charges, Including Drug Delivery and Bribery - Inforney News
Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial - The Lancet
Top 6 Healthcare Stock Picks in 2025 - timothysykes.com
Hypercholesterolemia Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com
Hypercholesterolemia Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight - Menafn.com
PCSK9 Inhibitors Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Statistics, Revenue, Pipeline, Therapies, and Companies by DelveInsight - The Globe and Mail
🐾 Pet of the Week: Meet Benny — Forney’s Frisbee-Loving Best Friend - Inforney News
Forney ISD Issues RFP for Security Guard Services Purchasing Contract Starting July 1 2025 - Inforney News
Crime Stoppers Most Wanted- Jose Raudel Muro-Ortega - Inforney News
Forney Hospital Project Set to Transform City Landscape - Inforney News
Vaccinex plans Nasdaq exit as Alzheimer market pressure grows - Pharmaceutical Technology
New Costco in Forney to Feature $3.5M Fuel Station - Inforney News
BJ's Coming to Forney with $10 Million Dollar Build at Hwy 80 & Gateway - Inforney News
Starbucks in Kroger Set for Remodel This Summer - Inforney News
Burlington to Open a New 22,000 Sq Ft Store at Village at Gateway, Expected to Welcome Shoppers by Early 2026 - Inforney News
Forney Costco Construction Updates: Breaking Ground In April, Won't Open Before TXDOT Bridge Completes - Inforney News
Governors Small Business Summit KaufmanA Sold Out Event - Inforney News
Texas Board Of Education Approves Optional Bible Curriculum In Public Schools - Inforney News
Kaufman's Community Economic Development Award - Inforney News
How a new kind of vaccine could lead to the eradication of Alzheimer's and dementia - New Scientist
Vaxxinity - The Pharma Letter
Study: Therapeutic Parkinson's vaccine safely inhibits alpha-synuclein clumps - Parkinson's News Today
Parkinson's Prevention May Include Tetanus Vaccination - Vax-Before-Travel
Vaxxinity’s Immunotherapy Meets Phase I Goals in Parkinson’s Patients - Inside Precision Medicine
A Potential Parkinson’s Treatment Has Promising Results - Time Magazine
Kaufman County and TXDOT Propose New Outer LoopPublic Input Session - Inforney News
Vaxxinity leaders detail retreat from 'abusive relationship' after 3 years on public market - Fierce Biotech
VAXX Stock Price and Chart — OTC:VAXX - TradingView
Terrell Breaks Ground On Northspur Development - Inforney News
Vaxxinity, Inc. (VAXX) Perplexes All, Surges 44% Amidst Delisting Decision - 富途牛牛
What's Driving These Stocks Higher In After-hours? - RTTNews
Why Is Vaxxinity (VAXX) Stock Down 58% Today? - InvestorPlace
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock - Yahoo Finance
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates - Yahoo Finance
Vaxxinity Inc Motivates Team with Option Repricing Initiative - TipRanks
Parkinson's Drug Reduces Disease Markers in Breakthrough Trial - ScienceAlert
AD/PD 2024: Vaxxinity reveals Phase I success with Parkinson’s vaccine - Pharmaceutical Technology
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024 - Yahoo Finance
Peek inside the Space Coast vaccine lab working to create humanity’s moonshot - WFTV
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published - Yahoo Finance
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024 - GlobeNewswire
Vaxxinity, University of Florida join for work on Parkinson’s vaccine - Parkinson's News Today
Scrip Asks…What Does 2024 Hold For Biopharma? Part 4: Transformative Technology - Citeline News & Insights
Vaxxinity Wants to Bring Accessible Vaccines for Chronic Illness to Market - cheddar.com
Vaxxinity, University of Central Florida launch collaboration to advance medicines for use in space - Fierce Biotech
Vaccines show promise against common chronic diseases - Gavi, the Vaccine Alliance
Vaxxinity making vaccines to change the world - Labiotech.eu
Vaxxinity, Inc. (VAXX) stock price, news, quote and history - Yahoo Finance Singapore
Researchers return to Alzheimer's vaccines, buoyed by recent drug success - Reuters
Vaxxinity earnings missed by $9.89, revenue fell short of estimates - Investing.com UK
Mei Mei Hu - The World Economic Forum
Rene Paula - Columbia Law School
Pursuing A "Biologic Revolution" With Vaxxinity's Mei Mei Hu - Bioprocess Online
Area fire departments fighting large grass fire north of Forney - Inforney News
Private companies invested in Vaxxinity, Inc. (NASDAQ:VAXX) copped the brunt of last week's US$41m market cap decline - Yahoo Finance
HEB announces expansion with new stores in Rockwall, Melissa, and Prosper - Inforney News
Vaxxinity to Present at Upcoming Investor Conferences in September - GlobeNewswire
Fast-Tracked Alzheimer’s Vaccine Seems to Work, But Phase 3 Trials Stalled - Being Patient
Molina Rene Paula Net Worth (2025) - GuruFocus
UB-311 vaccine found safe, slows decline in mild Alzheimer’s: Trial - Alzheimer's News Today
Vaxxinity publishes positive results in Alzheimer’s trial - Longevity.Technology
Innovative Alzheimer's Disease Vaccine Candidate Can Add Value - Vax-Before-Travel
Anti-amyloid drug shows significant immune response in adults with mild Alzheimer’s - Healio
Upcoming Events - FinancialContent
Vaxxinity Reports Second Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewswire
0.31%
0.33%
Capitalizzazione:
|
Volume (24 ore):